[Form 4] Monro, Inc. Insider Trading Activity
Rhea-AI Filing Summary
Peter J. Solomon, a director of Monro, Inc. (MNRO), was granted 8,306 restricted shares under the company’s Amended and Restated 2007 Stock Incentive Plan on 08/12/2025. The award vests in three equal annual installments, and the grant was reported with a $0 purchase price, indicating a service-based equity award rather than a cash purchase.
After the grant Mr. Solomon is reported to directly beneficially own 709,028 shares (which include 10,000 Class C Preferred shares presently convertible into 612,752 common shares). He also has indirect interests of 678,700 shares held in trusts for family (including 9,664 Class C Preferred convertible into 592,164 common shares) and 1,000 shares held by his spouse; he disclaims beneficial ownership of the trust holdings.
Positive
- Director received equity compensation aligning his interests with shareholders through an 8,306 restricted share award.
- Vesting over three years (one-third each year) supports retention and long-term alignment.
- Clear disclosure of direct holdings and indirect trust and spouse holdings, including convertible Class C Preferred details.
Negative
- None.
Insights
TL;DR: Routine director equity grant with multi-year vesting; disclosure clarifies direct and indirect holdings and trust-related disclaimers.
The Form 4 documents a standard restricted stock award to a non-executive director under the company’s 2007 plan, with vesting in three equal annual tranches. Reporting of both direct ownership (709,028 shares) and indirect interests through trusts and spouse provides transparency around potential beneficial ownership. The trustee relationship and explicit disclaimer of ownership for trust-held shares are important for governance clarity but do not, on their face, signal control shifts or related-party transactions requiring further corporate action.
TL;DR: The grant is a compensation event, not a market-moving disposition; holdings remain concentrated but largely unchanged in nature.
This filing records an equity compensation grant of 8,306 restricted shares granted at no cash price and vesting over three years, which is consistent with retention-focused director pay. The report also discloses significant aggregate direct holdings (709,028 shares) and indirect trust interests (including convertible Class C Preferred positions). From a market-impact perspective, no sale or transfer is reported, and the award itself implies potential future dilution only if and when conversion or vesting triggers issued shares.